Slides
Page 1
FINANCIAL PERFORMANCEQ2 & H1 FY26-27
Page 2
The Presentation is to provide the general background information about the company’s activities as at the date of the presentation. Theinformation contained herein is for general information purposes only and based on estimates and should not be considered as arecommendation that any investor should subscribe or purchase the company shares. The company makes no representation or warranty,express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness orcorrectness of any information contained herein.This presentation may include certain “forward looking statements”. These statements are based on current expectations, forecasts andassumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from thesestatements. Important factors that could cause actual results to differ materially from our expectations include, amongst others, generaleconomic and business conditions in India and abroad, ability to successfully implement our strategy, our research and developmentefforts, our growth and expansion plans and technological changes, changes in the value of the rupee and other currencies, changes in theIndian and international interest rates, change in laws and regulations that apply to the Indian and global chemical and pharmaceuticalsindustries, increasing competition, changes in political conditions in India or any other country and changes in the foreign exchangecontrol regulations in India. Neither the company, nor its directors and any of the affiliates or employee have any obligation to update orotherwise revise any forward-looking statements. The readers may use their own judgment and are advised to make their own calculationsbefore deciding on any matter based on the information given herein.No part of this presentation may be reproduced, quoted or circulated without prior written approval from Best Agrolife Ltd. DISCLAIMER
Page 3
Management’s commentTABLE OF CONTENTS Patent & Latest Launches Q2 & H1 FY27 HighlightsRegistrations & Global presenceCompany Snapshot This image cannot currently be displayed. This image cannot currently be displayed. This image cannot currently be displayed. This image cannot currently be displayed. This image cannot currently be displayed.
Page 4
*Agropages Top 20 Indian Agrochemical Companies 43Warehouses21 States12+PatentedProducts10,900+DealersManufacturing units7,000 MTPA Technical35,500 KL Formulation4530+FormulationsRegistrations800+Employees2R&D CentersGlobal presence in Brazil, China, Mauritius, UK4 COMPANY OVERVIEW
Page 5
“Q2FY27was a challenging quarter for the domestic crop protection industry. Irregularmonsoonrainfall delayedanduneven sowing,moisture stressandlimited irrigation availabilityacross severalagricultural regions affectedcrop establishmentand the timing ofcrop protectionapplications.These factors, coupled with cautious farmer spending andheightened competitive intensity, createdsignificant headwindsfor the business.Despite these challenges, we delivered a strong improvement in profitability, withEBITDAgrowing30%inQ2FY27and45%inH1FY27. An important contributor to our margin expansion has beenourstrategic shiftover the past two years towards astronger patented product portfolio,complemented by our continued focus oncost disciplineandoperational efficiency. We intend tobuild on this progress by furtherstrengtheningour patented portfolio, withinnovationandintellectual propertyat the core of ourlong-term growth strategy.During the period, we secured a patent grant for the combination ofFluxametamide,AbamectinandTrifloxystrobinand advanced our international business through a47-metric-tonneshipment toSudan, registration of our patented productRonfenTMinNepal, and registration ofLambda technicalinMexico. Withfouradditional products submitted for registration inNepal, we continue to pursueopportunities to expand ourinternational presenceandbroadenourgrowth platform.As we enter thesecond halfofFY27, the domestic outlook will depend on the progress ofRabisowing,soil moistureconditions,irrigationavailability andfarmers’ investmentin crop protection.Our priorities remainstrengtheningdomestic marketexecution, expanding ourpatented portfolioand pursuinginternationalgrowthopportunities. While market conditions remain uncertain, we willcontinue to focus oninnovation,operational disciplineandsustainable,profitable growthover thelong term. ” Mr. Vimal KumarManaging Director FROM MD’S DESK
Page 6
FY22-23FY23-24 FY24-25FY25-26Trifloxystrobin - 6%Thiamethoxam - 24%Thiophanate Methyl - 9.5%Crops - Okra, SoyabeanPests - Aphids, Whitefly,Leaf HopperWARDEN EXTRATMInsecticide + Fungicide (FS) Chlorantraniliprole - 0.45%Fipronil - 0.5%Emamectin Benzoate - 0.18%Crops - TomatoPests - Whitefly & Fruit BorerFETAGENTMInsecticide (GR) Chlorantraniliprole - 4.5%Novaluron - 11.5%Emamectin Benzoate - 1.5%Crops - BrinjalPests - BorerNEMAGENTMInsecticide (SC) Pyriproxyfen - 8%Dinotefuran - 5%Diafenthiuron - 18%Crops - Brinjal, Cotton, Chilli Pests - Sucking Pests & MitesRONFENTMInsecticide (SC) Haloxyfop-R Methyl - 12.8%Imazethapyr - 10%Crops - SoyabeanWeeds - Grasses & SedgesSHOT DOWNTMHerbicide (ME) Trifloxystrobin - 10%Difenoconazole - 12.5%Sulfur - 3%Crops - Tomato, Paddy, AppleFungus - Scab, Early & Late BlightTRICOLORTMFungicide (SC) P A T E N T P O W E R Fipronil- 7%Abamectin - 1.25%Tolfenpyrad - 15%Crops - Okra, ChilliPests - Aphids, Jassid, Thrips, Whitefly, Mites, Borer BEST MANTMInsecticide (SC) Pymetrozine - 30%Dinotefuran - 10%Pyraclostrobin - 20%Crops - PaddyMajor Pests/Fungus - BPH &BlastDINOTREXTMInsecticide + Fungicide (WG) FY24-25 KEY PATENTED PRODUCTS
Page 7
Trifloxystrobin - 4% Fluxapyroxad - 6.66% Clothianidin - 25% Crops - GroundnutPests - Stem Rot, Collar Rot, Root Rot, Tikka Leaf spot, Rust, Termites, Thrips & White grubsFLUZAMTMInsecticide + Fungicide (FS) Spiromesifen - 15%Hexythiazox - 2.2%Abamectin - 1.15%Crops - ChilliPests - Yellow mitesand Black thripsCUBAX POWER EXTRATMInsecticide (SC)lsoprothiolane - 15%Trifloxystrobin - 2.5%Pymetrozine - 7.5%Crops - PaddyPests - Sheath blight,Blast, Brown plant hopper,Green Leaf Hopper.MIDCOTINTMInsecticide + Fungicide (SE)PAT E N T E D I N N O VAT I O N S . P R O V E N P E R F O R M A N C E . LATEST LAUNCHES: PATENTED
Page 8
It is a highly concentratedAscophyllum nodosum 15%based bio-stimulant thatpromotes stronger rootdevelopment and better nutrientuptake. It helps crops withstandheat and drought stress whilesupporting healthier and moreproductive growth.SPRINKTMIt is an organic potassiumsolution derived fromRhodophytes that supportsboth crop productivity and soilhealth. It improves nutrientbalance, strengthens plants,and enhances overall cropperformance naturally.PUNCTUALTMIt is a powerful bio-stimulant enriched with humicacid, amino acids, vitamins, andbioactive compounds. It improvessoil health, enhances nutrientabsorption, and promotes robustplant growth and resilience.TORNETTMIt is a plant-based amino acidformulation enriched witholigopeptides and polypeptidesto improve crop vitality. Itenhances photosynthesis,boosts nutrient uptake, andpromotes stronger, healthierplant growth.EMPROLETM It harnesses the natural power ofseaweed to stimulate vigorousplant growth and improveflowering and fruiting. It enhancesoverall crop health, leading tohigher-quality produce andimproved yields.RICHGROW GOLDTMN AT U R E ' S I N T E L L I G E N C E . E N H A N C E D C R O P P E R F O R M A N C E . LATEST LAUNCHES: BIO-FERTILIZERS / PLANT GROWTH REGULATORS
Page 9
Obtained the patentgrant for the combination of Fluxametamide + Abamectin + Trifloxystrobin, to support our broader focus on developing differentiated products.Secured 13 New Central Insecticides Board (CIB) registrations this quarter in various categories, strengthening our product portfolio, mainly: 1. 9(3) FIM -Fluxametamide 5% + Flonicamid 15% + Abamectin 1.5% ME2. 9(3) FIM vs FI •Fluxapyroxad 333g/l FS•Fluxametamide 10% w/w EC3. 9(4) TIM -Cyclaniliprole Technical 95.00% w/w min 4. 9(4) FIM -10•Sudan: We are pleased to announce the successful completion of a 47MT shipment, marking a significant milestone in our operations. •Nepal: We have achieved one patented product registration, with four additional products submitted for registration and expected to receive approval in the near future. •Mexico: We have secured registration for one technical product in Mexico, while another is currently in progress. This achievement marks our successful entry and presence in the LATAM region. •Taiwan: One product has reached the final stage of approval, and a second product is also progressing well through the review process. •Sri Lanka: Samples of our two patented products are set to undergo testing, as both have received initial approval and will now advance to the trial phase.Global RegistrationsDomestic RegistrationsPATENT & REGISTRATIONS
Page 10
Value (INR Cr) Q2 FY27 Q2 FY26 % Y-o-YRevenue from Operations407 517 (21)%Gross Margin182 170 7%Gross Margin (%)45% 33% 1,185 bpsEBITDA*101 78 30%EBITDA Margin (%)25% 15% 969 bpsProfit After Tax 57 39 48%PAT Margin (%)14% 8% 651 bps*EBITDA is calculated excluding other income •Revenue for Q2 FY27 stood at ₹407 crore, compared to ₹517 crore in Q2 FY26, reflecting a 21% YoY decline, due to erratic rainfall, delayed sowing and lower crop protection demand .•Gross Margin improved significantly to 45% in Q2 FY27 from 33% in Q2 FY26,supported by stronger patented product portfolio.•EBITDA Margin improvedsignificantly to 25% in Q2 FY27 from 15% in Q2 FY26, reflecting improved gross margins and operational efficiencies.•With Strategic restructuring across regional operations the Company has achieved OPEX reduction of 12%in comparison to Q2 FY26. •Profit After Tax for Q2 FY27 increased to ₹57 crore, compared to ₹39 crore in Q2 FY26, registering a growth of 48% YoY.•The share of patented products increased from 51%in Q2 FY26 to 60%in Q2 FY27, reflecting a strategic shift toward innovation, proprietary formulations, and higher-margin offerings.•Q2 FY27 witnessed strong sequential growth in Revenue, Gross Margins, EBITDA, and PAT compared to Q1 FY27. HIGHLIGHTS Q2 FY27
Page 11
*EBITDA is calculated excluding other income FINANCIAL HIGHLIGHTS Q2 FY27(₹ Crore)Revenue from operations517 407Q2 FY26 Q2 FY27-21%EBITDA*(₹ Crore)78 101Q2 FY26 Q2 FY2730%PAT(₹ Crore)39 57Q2 FY26 Q2 FY2748%1.101.62Q2 FY26 Q2 FY27EPSBranded v/s Institutional Sales69% 81%31%19%Q2 FY26 Q2 FY27Branded Institutional SalesContribution of Patented products in Branded Sales51% 60%49%40%Q2 FY26 Q2 FY27Patented Non-Patented41%
Page 12
Value (INR Cr) H1 FY27 H1 FY26 % Y-o-YRevenue from Operations803 898(11)%Gross Margin328 28017%Gross Margin (%)41% 31%960 bpsEBITDA*178 12345%EBITDA Margin (%)22% 14%846 bpsProfit After Tax 98 5967%PAT Margin (%)12% 7%553 bps*EBITDA is calculated excluding other income •Revenue for H1 FY27 stood at ₹803 crore, compared to ₹898 crore in H1FY26, reflecting a 11% YoY decline, due to erratic rainfall, delayed sowing and lower crop protection demand .•Gross Margin improved significantly to 41% in H1 FY27 from 31% in H1 FY26,supported by stronger patented product portfolio.•EBITDA Margin improvedsignificantly to 22% in H1 FY27 from 14% in H1 FY26, reflecting improved gross margins and operational efficiencies.•With Strategic restructuring across regional operations the Company has achieved OPEX reduction of 5%in comparison to H1 FY26. •Profit After Tax for H1 FY27 increased to ₹98 crore, compared to ₹59 crore in H1 FY26, registering a growth of 67% YoY.•The share of patented products increased from 49%in H1 FY26 to 63%in H1 FY27, reflecting a strategic shift toward innovation, proprietary formulations, and higher-margin offerings. HIGHLIGHTS H1 FY27
Page 13
*EBITDA is calculated excluding other income(₹ Crore)Revenue from operations898 803H1 FY26 H1 FY27-11%EBITDA*(₹ Crore)123 178H1 FY26 H1 FY2745%PAT(₹ Crore)59 98H1 FY26 H1 FY2767%1.662.77H1 FY26 H1 FY27EPSBranded v/s Institutional SalesContribution of Patented products in Branded Sales67% 71%33%29%H1 FY26 H1 FY27Branded Institutional Sales49% 63%51%37%H1 FY26 H1 FY27Patented Non-Patented67% FINANCIAL HIGHLIGHTS H1 FY27
Page 14
Value (INR Cr) As on Sept 30, 2026 As on Sept 30, 2025 As on Mar 31, 2026Equity And LiabilitiesShare Holders Fund864809 769Non-current Liabilities•Long Term Borrowings7312 27•Other Financial Liabilities3833 32Total Non-current Liabilities11145 59Current Liabilities•Short Term Borrowings382413 406•Trade Payable425554 319•Other Current Liabilities175142 133Total Current Liabilities9821,109 858Total Equity & Liability1,9571,963 1,686AssetsNon-current Assets•Net Fixed Asset149164 157•Intangible Asset5158 55•Other Non Current Assets166156 163Total Non-current Assets366378 375Current Assets•Inventories786666 651•Trade Receivables613783 490•Cash & Bank Balance8369 98•Other Current Assets10967 72Total Current Assets1,5911,585 1,311Total Assets1,9571,963 1,686 CONSOLIDATED BALANCE SHEET
Page 15
*Formulae: ROCE= EBIT/ Capital Employed*100 (Capital Employed = Total Assets – current liabilities + Short term borrowings)Debt to Equity = Total Debt / Shareholders fund; Net Debt to Equity = Total Debt - Cash & Bank Balances / Shareholders fundCurrent ration = Current Assets / Current liabilities 0.900.480.440.43FY24 FY25 FY26 H1 FY27Net Debt to EquityCurrent Ratio1.211.371.531.62FY24 FY25 FY26 H1 FY270.970.620.560.53FY24 FY25 FY26 H1 FY27Debt to EquityROCE15%13%5%7%FY24 FY25 FY26 H1 FY27(Not Annualized) Improvement in key financial ratios reflects a stronger balance sheet, reduced leverage, enhanced liquidity, and improved capital efficiency.KEY RATIOS
Page 16
Improvement across key working capital metrics reflects enhanced operational efficiency, better cash flow management, and a stronger financial position.Receivable Days151 124FY26 H1 FY27Inventory Days292 272FY26 H1 FY27Working Capital Days247 207FY26 H1 FY27Cash Conversion Days267 255FY26 H1 FY27 WORKING CAPITAL MOVEMENT
Page 17
Mr. Vimal KumarManaging DirectorA true visionary and a passionateentrepreneur, Mr Vimal Kumar is aneminent personality with vast and richexperience in the Agrochemicals Industry.He oversees strategy, management,development, and integration of thecompany policies. With Best Agrolife he ispioneering endeavors to provide farmerswith safe agrochemical products ateconomical prices.He has been Interviewed by internationalmagazines from “African Farming andFood Processing” to the publication AgroPages, where he spoke on the “TakingIndian Brands and Leaders. Stridestowards Make in India”. In the 2018edition of India Suppliers Guide, Mr.Vimal’s views were published as “AnAgrochemical Perspective from India”. In2019, he was featured in the Forbes Indiamagazine’s & in 2022 featured in FortuneIndia magazine.Mr. P . N. KarlekarManaging Director (BCS)A chemical Engineer from UDCT- one ofthe top Indian Institute for ChemicalTechnology and a Management Graduatefrom Mumbai University, he has a diverseand rich professional background.He has been associated at the apex levelwith reputed organizations such as -RallisIndia Ltd as President Technology,thereafter worked at leadership levelsincluding as President of theAgrochemical division of Atul Ltd, as COOof Deepak Nitrite Ltd., as ManagingDirector of Cheminova India Ltd from2008 and subsequently as its Presidentinternational region comprising of Asia-Pacific, Africa, Middle East. Later on, post-global acquisition of Cheminova by FMCcorp (USA), he assumed the position ofcountry head for FMC India. In theseassignments he worked on strategic areassuch as mergers and acquisitions andglobal business development etc.A passionate technologist andentrepreneur having 31 years of extensiveexperience and understanding ofOrganizational Program Management,Business Analytics, Innovation, StartupCulture and Technology. He has heldvarious leadership positions at private andgovernment sectors with national andinternational exposure. In his 15 years stintat Wipro Technologies, held the roles ofDelivery Head (PES), Program Head ofMicrosoft Windows SustenanceEngineering Services, Head of Cost ofDelivery Optimization.As a scientist with DRDO he worked ontechnology development and R&D forcritical systems of national importance. Hewas instrumental in creating India’s firstQuantum Secure Communication Stack forNational Agencies.In his earlier stint with Best Group,The R&D environment created by himestablished a foundation formanufacturing of next generationmolecules.Mr. Sanjeev Bajaj is a seasoned finance professionaland Chartered Accountant with nearly two decadesof extensive experience across financial reporting,group consolidation, controllership, audit andassurance, finance transformation, and regulatorycompliance.Prior to joining Best Agrolife Limited, Mr. Bajajspent over six years in leadership roles at PIIndustries, one of India’s leading agro-sciencescompanies. During his tenure, he developed acomprehensive understanding of the agrochemicalvalue chain, manufacturing operations, regulatoryrequirements, and global business practices. Earlierin his career, Mr. Bajaj spent nearly nine years withPrice Waterhouse, where he led audit andassurance engagements for prominent listed Indiancompanies and multinational corporations. Withsuch diverse experience he brings a strong focuson financial discipline, robust governance, effectiverisk management contributing to sustainablegrowth and long-term organizational valuecreation.Mr. Sanjeev BajajChief Financial OfficerMr. N Surendra SaiExecutive Director EXPERIENCED MANAGEMENT TEAM
Page 18
D I S C L A I M E RThis presentation includes certain forward looking statements and information including statementsconcerning the outlook for business. The statements are based on certain expectations, assumptions,anticipated developments and other factors which are not limited to, risks, uncertainties andassumptions based on current expectations, within the meaning of applicable laws and regulations.Forward-looking statements are based on current expectations, estimates and projections about thefactors that may affect our future performance, including global economic conditions. Theexpectations, estimations and projections are majorly identified by the use of words such as"anticipates, "believes," "estimates," "expects," "intends," "plans," "predicts," "projects" and similarexpressions. There are numerous risk and uncertainties, way beyond our control, that could cause ouractual results to differ from the forward looking information and statements made in thispresentation. The company, based on changes stated above, may alter, amend, modify or makenecessary changes in any manner to any such forward looking statement contained herein or make,written or oral forward looking statement as may be required from time to time basis of subsequentdevelopments and events. No part of this presentation may be reproduced, quoted or circulatedwithout the prior approval from Best Agrolife Ltd. Contact Us:ir@bestagrolife.com(Investor Relations)T H A N K Y O U ! ! !